£107.50

Springer Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£109.70 £107.28 £107.81 £108.34 £108.86 £109.39 £109.92 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
20 days · current 70 days 0 18 35 53 70 £108 £110 Days at Price

Price Analysis

Most common price: £110 (70 days, 77.8%)

Price range: £108 - £110

Price levels: 2 different prices over 90 days

Description

Product Description This is the first book to assemble the leading researchers in the field of LRRK2 biology and neurology and provide a snapshot of the current state of knowledge, encompassing all major aspects of its function and dysfunction. The contributors are experts in cell biology and physiology, neurobiology, and medicinal chemistry, bringing a multidisciplinary perspective on the gene and its role in disease. The book covers the identification of LRRK2 as a major contributor to the pathogenesis of Parkinson's Disease. It also discusses the current state of the field after a decade of research, putative normal physiological roles of LRRK2, and the various pathways that have been identified in the search for the mechanism(s) of its induction of neurodegeneration. From the Back Cover This is the first book to assemble the leading researchers in the field of LRRK2 biology and neurology and provide a snapshot of the current state of knowledge, encompassing all major aspects of its function and dysfunction. The contributors are experts in cell biology and physiology, neurobiology, and medicinal chemistry, bringing a multidisciplinary perspective on the gene and its role in disease. The book covers the identification of LRRK2 as a major contributor to the pathogenesis of Parkinson's Disease. It also discusses the current state of the field after a decade of research, putative normal physiological roles of LRRK2, and the various pathways that have been identified in the search for the mechanism(s) of its induction of neurodegeneration.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Protein Serine/Threonine Kinases in Neurodegenerative Disorders
82% match

Protein Serine/Threonine Kinases in Neurodegenerative Disorders

Academic Press

£157.99 11 May 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
81% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
81% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.86 11 May 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
80% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 18 May 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
80% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£50.22 10 May 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
79% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 18 May 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
79% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£142.46 18 May 2026
79% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Academic Press

£157.99 11 May 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
79% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Academic Press

£156.19 19 May 2026
Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)
79% match

Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)

Springer

£113.94 18 May 2026
Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)
79% match

Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)

Springer

£102.43 04 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
79% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.11 18 May 2026
Neurodegenerative Disorders: A Clinical Guide
79% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 17 May 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers: 2
79% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers: 2

Springer

£110.42 11 May 2026
Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice
79% match

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Academic Press

£137.99 11 May 2026
Systems Biology of Parkinson's Disease
78% match

Systems Biology of Parkinson's Disease

Springer

£106.53 18 May 2026
Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research
78% match

Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research

Springer

£76.38 18 May 2026
Neuropsychiatric Disorders
78% match

Neuropsychiatric Disorders

Springer

£107.98 11 May 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
77% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£107.98 18 May 2026
The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)
77% match

The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)

Springer

£111.43 18 May 2026
Cellular and Molecular Control of Neuronal Migration: 800 (Advances in Experimental Medicine and Biology, 800)
77% match

Cellular and Molecular Control of Neuronal Migration: 800 (Advances in Experimental Medicine and Biology, 800)

Springer

£107.05 18 May 2026
Neuroproteomics: Methods and Protocols: 1598 (Methods in Molecular Biology, 1598)
77% match

Neuroproteomics: Methods and Protocols: 1598 (Methods in Molecular Biology, 1598)

Humana

£89.12 18 May 2026
77% match

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management

Academic Press

£133.99 10 May 2026
Development and Engineering of Dopamine Neurons
77% match

Development and Engineering of Dopamine Neurons

Springer

£106.61 18 May 2026